A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder

被引:116
作者
Holmes, J
Payton, A
Barrett, JH
Hever, T
Fitzpatrick, H
Trumper, AL
Harrington, R
McGuffin, P
Owen, M
Ollier, W
Worthington, J
Thapar, A
机构
[1] Univ Wales Coll Cardiff, Coll Med, Dept Med Psychol, Child & Adolescent Psychiat Sect, Cardiff CF14 4XN, S Glam, Wales
[2] Univ Manchester, Royal Manchester Childrens Hosp, Dept Child & Adolescent Psychiat, Manchester, Lancs, England
[3] Univ Manchester, ARC, Epidemiol Unit, Manchester M13 9PL, Lancs, England
[4] Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England
基金
英国医学研究理事会;
关键词
attention deficit hyperactivity disorder (ADHD); DAT1; DRD4; dopamine; genetics; association;
D O I
10.1038/sj.mp.4000751
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Attention deficit hyperactivity disorder (ADHD) is a highly heritable psychiatric condition of early childhood onset characterised by marked inattention, hyperactivity and impulsiveness. Molecular genetic investigations of ADHD have found positive associations with the 480-bp allele of a VNTR situated in the 3' untranslated region of DAT1 and allele 7 of a VNTR in exon 3 of DRD4. A number of independent studies have attempted to replicate these findings but the results have been inconsistent. We used both family-based and case control approaches to examine these polymorphisms in a sample of 137 children diagnosed with ICD-IO, DSM-IV or DSM-III-R ADHD. We found no evidence of association with the DAT1 polymorphism, despite a sample size that has up to 80% power to detect a previously reported effect size. We observed a significant increase in the DRD4 7 repeat allele amongst ADHD probands (21.7%) and their parents (18.9% in mothers, 22.3% in fathers), compared to ethnically matched controls (12.8%). However TDT analysis showed no preferential transmission of allele 7 to ADHD probands.
引用
收藏
页码:523 / 530
页数:8
相关论文
共 30 条
[1]  
ANGOLD A, 1995, PSYCHOL MED, V25, P739, DOI 10.1017/S003329170003498X
[2]  
Asherson P, 1998, AM J MED GENET, V81, P549
[3]  
Bruun TG, 1999, MOL PSYCHIATR, V4, P414
[4]   Genomewide transmission/disequilibrium testing: A correction [J].
Camp, NJ .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 64 (05) :1485-1487
[5]   Lack of an association between a dopamine-4 receptor polymorphism and attention-deficit/hyperactivity disorder: genetic and brain morphometric analyses [J].
Castellanos, FX ;
Lau, E ;
Tayebi, N ;
Lee, P ;
Long, RE ;
Giedd, JN ;
Sharp, W ;
Marsh, WL ;
Walter, JM ;
Hamburger, SD ;
Ginns, E ;
Rapoport, JL ;
Sidransky, E .
MOLECULAR PSYCHIATRY, 1998, 3 (05) :431-434
[6]  
COOK EH, 1995, AM J HUM GENET, V56, P993
[7]  
CURTIS D, 1995, AM J HUM GENET, V56, P811
[8]   Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children [J].
Daly, G ;
Hawi, Z ;
Fitzgerald, M ;
Gill, M .
MOLECULAR PSYCHIATRY, 1999, 4 (02) :192-196
[9]  
Faraone SV, 1999, MOL PSYCHIATR, V4, pS81
[10]   Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism [J].
Gill, M ;
Daly, G ;
Heron, S ;
Hawi, Z ;
Fitzgerald, M .
MOLECULAR PSYCHIATRY, 1997, 2 (04) :311-313